Skip to main content
OpenTrials
Completed

NCT Number: NCT01932853

Association Between Dose Dialysis by Kt and Mortality

The aim of this study is to assess whether patients receiving current recommendations of an adequate dialysis dose by Kt adjusted for body surface area improved survival at 24 months compared to those who do not get it, as well as assess whether patients receiving a dose greater obtain more benefit.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • > 18 years old
  • > six months on hemodialysis
  • Receiving 3 sessions of dialysis per week
  • Having 5 or more valid measures of Kt during the month

Exclusion criteria

  • active chronic inflammatory diseases
  • Liver cirrhosis
  • Neoplasms
  • Chronic immunosuppression or use of anti-inflammatory

Treatment and study plan

Primary outcomes

  1. Mortality

    Time frame: two years

Secondary outcomes

  1. Hospitalization

    Time frame: two years

Other outcomes

  1. Mortality and hospitalization cause

    Time frame: two years

Sponsors and collaborators

Lead sponsor

NephroCare Spain

Industry

Registry information

Official study title

Evaluation of the Association of Dialysis Dose Obtained by Kt and Mortality in Hemodialysis Patients

Important dates

Study start
2013
Primary completion
2013
Study completion
2015
First posted
Aug 30, 2013
Registry last updated
Jul 13, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.